首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato) oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats
【24h】

An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato) oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats

机译:一种口服活性的抗糖尿病钒钒配合物,双(1-氧-2-吡啶硫基)氧钒(IV),具有VO(S2O2)配位模式;大鼠体内和体外评价

获取原文
获取原文并翻译 | 示例
           

摘要

According to Pearson's HSAB (hard and soft acids and bases) rule, the vanadyl ion is classified as a hard acid. However, vanadyl-cysteine methyl ester and dithiocarbamate complexes with VO(S2N4) and VO(S-4) coordination modes, respectively, that contain bonds with a combination of hard acid (VO2+) and soft base (sulfur) have been found to form stable complexes and exhibit insulin-mimetic activities in in vitro and in vivo evaluations. Based on such observations, a purple bis(1-oxy-2-pyridinethiolato) oxovanadium(IV) (VO(OPT)) complex with VO(S2O2) coordination mode was prepared and found to have a strong insulin-mimetic activity in in vitro evaluation, which followed in vivo effectiveness on intraperitoneal injection and oral administration. Then, we examined the real-time ESR analysis of vanadyl species in the blood of live rats given VO(OPT) by use of the blood circulation monitoring-ESR method. The clearance of vanadyl species from the blood in terms of half-life (t(1/2)) was determined as 15 min in VO(OPT)-treated rats, while t(1/2) of VOSO4-treated rats was 5 min, indicating the long-term acting character of VO(OPT). On the basis of the results, VO(OPT) with VO(S2O2) coordination mode is proposed to be a potent orally active insulin-mimetic complex in treating insulin-dependent diabetes mellitus in experimental animals. (C) 2000 Elsevier Science Inc. All rights reserved. [References: 23]
机译:根据Pearson的HSAB(硬酸和软酸和碱)规则,钒氧根离子归为硬酸。但是,已发现形成了分别具有VO(S2N4)和VO(S-4)配位模式的钒基-半胱氨酸甲酯和二硫代氨基甲酸酯配合物,它们包含与硬酸(VO2 +)和软碱(硫)结合的键稳定的复合物,并在体外和体内评估中表现出模拟胰岛素的活性。基于这些观察结果,制备了具有VO(S2O2)配位模式的紫色双(1-氧-2-吡啶硫代巯基)氧钒(IV)(VO(OPT))配合物,并在体外具有较强的模拟胰岛素活性评估,然后进行腹膜内注射和口服给药的体内有效性。然后,我们使用血液循环监测-ESR方法检查了给予VO(OPT)的活大鼠血液中钒基物质的实时ESR分析。在半衰期(t(1/2))方面,在VO(OPT)处理的大鼠中从血液中清除钒基物质的清除时间为15分钟,而VOSO4处理的大鼠的t(1/2)在血液中的清除率为5分钟min,表示VO(OPT)的长期作用特性。根据这些结果,VO(OPT)和VO(S2O2)配位模式被认为是一种有效的口服活性胰岛素模拟复合物,可用于治疗实验动物的胰岛素依赖型糖尿病。 (C)2000 Elsevier Science Inc.保留所有权利。 [参考:23]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号